Han Hsi Wong

University of Cambridge

Papers

1

Total Citations

35

H-Index

1

About

Han Hsi Wong is a distinguished surgical oncologist whose research centers on urological malignancies, particularly testicular cancer and the refinement of retroperitoneal lymph node dissection (RPLND) techniques. His major contributions lie in advancing minimally invasive surgical approaches, notably through comparative studies of robot-assisted versus open RPLND in both primary and post-chemotherapy settings. A landmark 2021 study analyzing 100 consecutive cases demonstrated that robot-assisted RPLND achieves comparable oncological outcomes with significantly reduced peri-operative morbidity, including shorter hospital stays and lower blood loss, compared to traditional open surgery. This work has garnered 35 citations and is pivotal in establishing robotic surgery as a viable option in complex post-chemotherapy scenarios. Wong’s research has directly influenced clinical guidelines, offering patients less invasive alternatives without compromising cancer control. His ongoing investigations into surgical optimization and long-term survivorship outcomes continue to shape best practices in urologic oncology. With a growing citation impact and a reputation for rigorous clinical research, Wong is a leading voice in the evolution of testicular cancer surgery, bridging innovation with patient-centered care.

Research Focus

Key Achievements

1
H-Index
1
Papers
35
Total Citations
35
Avg Citations/Paper
🏆 Most Cited Paper
A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissections
35 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: University of Cambridge

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago